CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.
The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
The Black Country Lung Cancer Screening Programme has seen a dramatic improvement in early detection rates, with 74 per cent of lung cancers now identified at an early stage – u ...
Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.
There is much to commend about Australia's lung cancer screening program, which started on July 1. Some people will have their life prolonged due to this screening, which involves taking low-dose CT ...
Social media advertising reached over one million adults eligible for lung cancer screening, showing a scalable way to boost ...
Among eligible populations, screening for breast and colorectal cancers was nearly four times more common than for lung cancer. Among those who never had lung cancer screening, roughly 60% had ...
A procedure that can help spot lung cancer early is now available at a hospital, saving patients long trips out of a county.
Lung cancer affects non-smokers, with 25% of patients having never smoked, highlighting the need for awareness of persistent symptoms and environmental risk factors. Genetic testing is essential for ...
The pledge comes ahead of the Holyrood elections in May.
Research shows a growing number of non- and never-smokers are getting diagnosed with lung cancer. Risks for never-smokers include poor air quality caused by pollution and wildfire smoke, occupational ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results